(NRIM) Northrim BanCorp - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6667621097
NRIM: Banking, Loans, Credit, Cards, Mortgages, Investments, Services
Northrim BanCorp Inc. (NASDAQ:NRIM) serves as the bank holding company for Northrim Bank, focusing on commercial banking products and services tailored for businesses and professionals. Operating through two key segments—Community Banking and Home Mortgage Lending—the company offers a comprehensive suite of financial services. This includes deposit accounts such as noninterest-bearing checking, interest-bearing time deposits, and individual retirement accounts, alongside various loan options like commercial loans and consumer loans. Additionally, Northrim provides an array of digital banking services, including online and mobile banking, debit and credit cards, and specialized cash management solutions. The company also offers investment advisory and wealth management services, positioning itself as a holistic financial partner in its market. Established in 1990 and headquartered in Anchorage, Alaska, Northrim has built a reputation for personalized service and community-focused banking. Web URL: https://www.northrim.com
Based on the provided data, Northrim BanCorp Inc. (NASDAQ:NRIM) demonstrates a strong financial position. The stock is currently trading at $80.58, slightly below its 20-day SMA of $85.31, indicating a potential buying opportunity if it rebounds. The 50-day SMA at $81.19 suggests a stable trend, while the 200-day SMA of $69.59 reflects long-term growth. With an ATR of 2.80, the stock shows moderate volatility. Fundamentally, the market cap of $461.82M, P/E of 12.64, and forward P/E of 10.67 indicate undervaluation and investor confidence in future growth. The P/B ratio of 1.76 and RoE of 13.84 highlight efficient operations and strong returns on equity. These metrics collectively suggest that NRIM is undervalued, offering a promising investment opportunity with potential for growth in the next quarter.
Additional Sources for NRIM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NRIM Stock Overview
Market Cap in USD | 455m |
Sector | Financial Services |
Industry | Banks - Regional |
GiC Sub-Industry | Regional Banks |
IPO / Inception | 1993-10-25 |
NRIM Stock Ratings
Growth Rating | 89.9 |
Fundamental | 81.4 |
Dividend Rating | 85.6 |
Rel. Strength | 39.3 |
Analysts | 5/5 |
Fair Price Momentum | 103.20 USD |
Fair Price DCF | 112.69 USD |
NRIM Dividends
Dividend Yield 12m | 3.24% |
Yield on Cost 5y | 14.43% |
Annual Growth 5y | 12.26% |
Payout Consistency | 98.5% |
NRIM Growth Ratios
Growth Correlation 3m | -31.9% |
Growth Correlation 12m | 79.4% |
Growth Correlation 5y | 88.5% |
CAGR 5y | 37.20% |
CAGR/Max DD 5y | 1.00 |
Sharpe Ratio 12m | 1.53 |
Alpha | 59.07 |
Beta | 1.119 |
Volatility | 34.91% |
Current Volume | 46.2k |
Average Volume 20d | 21.8k |
As of May 09, 2025, the stock is trading at USD 83.97 with a total of 46,162 shares traded.
Over the past week, the price has changed by +4.10%, over one month by +21.91%, over three months by -4.18% and over the past year by +70.48%.
Yes, based on ValueRay Fundamental Analyses, Northrim BanCorp (NASDAQ:NRIM) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 81.38 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NRIM as of May 2025 is 103.20. This means that NRIM is currently undervalued and has a potential upside of +22.9% (Margin of Safety).
Northrim BanCorp has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy NRIM.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, NRIM Northrim BanCorp will be worth about 118.2 in May 2026. The stock is currently trading at 83.97. This means that the stock has a potential upside of +40.78%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 99.5 | 18.5% |
Analysts Target Price | 99.5 | 18.5% |
ValueRay Target Price | 118.2 | 40.8% |